HLS Therapeutics Inc. HLS.TO
Set alert
4.51 CAD -0.05 -1.10%
As of Oct 30, 4:00 PM ET
4.38 Day range 4.55
3.60 52-week range 5.58
- YTD
- -6.43%
- 1 year
- -18.74%
- Open
- 4.51
- Prev close
- 4.56
- Mkt cap
- 139.52M
- Vol
- 35.74K
- Avg vol
- 73.53K
- EPS
- -0.37
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.38
- High
- 4.55
- Forward P/E
- -7.50
- Beta
- 1.07
- Short ratio
- 0.10
- Inst. own
- 65.14%
- Dividend
- 0.00
- Ex-div date
- Apr 26, 2023
- 50-d avg
- 3.54
- 200-d avg
- 3.70
- 1y target
- 6.09
2Y chart
Signals (80)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 27, 2026 | 4 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| RSI: Oversold | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 23, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 22, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 7, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
| RSI: Overbought | Apr 29, 2026 | 6 months ago |
| RSI: Overbought | Apr 17, 2026 | 6 months ago |
| SMA: Bullish | Apr 10, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 11, 2026 | 7 months ago |
| RSI: Oversold | Mar 11, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 10, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 5, 2026 | 8 months ago |
| RSI: Oversold | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 11, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 29, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 20, 2026 | 9 months ago |
| RSI: Oversold | Jan 14, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 13, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 31, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 24, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 9, 2025 | 10 months ago |
| SMA: Bearish | Dec 3, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 27, 2025 | 11 months ago |
| SMA: Bullish | Nov 14, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| RSI: Oversold | Nov 13, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 28, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 19, 2025 | 1 year ago |
| RSI: Overbought | Sep 18, 2025 | 1 year ago |
| RSI: Overbought | Sep 8, 2025 | 1 year ago |
| RSI: Overbought | Aug 28, 2025 | 1 year ago |
| RSI: Overbought | Aug 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 25, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 5, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 30, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| RSI: Overbought | Mar 20, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| SMA: Bullish | Mar 18, 2025 | 1 year ago |
| SMA: Bearish | Mar 7, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 13, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 29, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 20, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 8, 2025 | 1 year ago |
Key statistics
- Market cap
- 119.22M
- Enterprise value
- 173.16M
- Trailing P/E
- 0.00
- Forward P/E
- -7.50
- PEG ratio
- 0.00
- Price / sales
- 2.09
- Price / book
- 1.50
- EPS (TTM)
- -0.99
- Beta
- 1.07
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -38.70%
- Revenue (TTM)
- 56.94M
- Revenue growth
- -12.20%
- Free cash flow
- 27.20M
- Total cash
- 17.54M
- Total debt
- 68.62M
- Return on equity
- -24.33%
- Shares outstanding
- 31.79M
- Short % of float
- 0.00%
- 50-day average
- 3.54
- 200-day average
- 3.70
Analyst view
Consensus: none
Price target (mean) 6.09 +35.0% upside
Now 4.51
- Target (low)
- 3.61
- Target (mean)
- 6.09
- Target (high)
- 9.81
Ratings (0m) 5 2 buy · 3 hold · 0 sell
- Strong buy0
- Buy2
- Hold3
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.09.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 18, 2024 | Raymond James | main | Market Perform | Market Perform |
| Aug 6, 2021 | Raymond James | down | Outperform | Market Perform |
About HLS Therapeutics Inc.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- hlstherapeutics.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on HLS.TO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Canoe Financial LP | 1.54% | 499,001 | 1.87M | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| DFA Investment Dimensions-Canadian Small Company Series | 0.06% | 20,104 | 75.39K | Jul 30, 2024 |
| Highland Fds II-Highland Global Allocation Fd | 0.03% | 10,445 | 39.17K | Sep 29, 2024 |
| DFA Investment Dimensions-DFA Va International Small | 0.01% | 2,903 | 10.89K | Jul 30, 2024 |
| DFA Investment Dimensions-World Ex U.S. Core Equity Port | 0.01% | 2,000 | 7.50K | Jul 30, 2024 |
| Lincoln VIP Tr-Dimensional International Core Equity Fd | 0.01% | 2,317 | 8.69K | Sep 29, 2024 |
| John Hancock Fds II-International Small Company Fund | 0.01% | 2,600 | 9.75K | Oct 30, 2024 |